Abstract 169 Table 1
Endpoints Amiodarone at time of HTx
(n=73)
No Amiodarone at time of HTx
(n=291)
P-Value
Incidence of Primary Graft Dysfunction,% 6.8% (5/73) 4.8% (14/291) 0.554
Mild PGD,% 0.0% (0/73) 1.0% (3/291) 1.000
Moderate PGD,% 5.5% (4/73) 2.7% (8/291) 0.265
Severe PGD,% 1.4% (1/73) 1.0% (3/291) 1.000
Endpoints High-Dose Amiodarone at time of HTx
(n=34)
Low-Dose Amiodarone at time of HTx
(n=37)
P-Value
Incidence of Primary Graft Dysfunction,% 5.9% (2/34) 8.1% (3/37) 1.000
Mild PGD,% 0.0% (0/34) 0.0% (0/37) 1.000
Moderate PGD,% 5.9% (2/34) 5.4% (2/37) 1.000
Severe PGD,% 0.0% (0/34) 2.7% (1/37) 1.000